等待开盘 11-26 09:30:00 美东时间
+0.920
+1.38%
Nutanix (NTNX) reported its first quarter fiscal 2026 financial results after the bell on Tuesday. Shares had plunged 13% during early post-market trading after its first-quarter revenue and 2026 outl...
今天 05:49
Whales with a lot of money to spend have taken a noticeably bullish stance on C...
今天 02:02
Oppenheimer analyst Brian Bittner reiterates Restaurant Brands Intl (NYSE:QSR) with a Outperform and maintains $80 price target.
今天 00:57
在经历上月9.231亿美元IPO后的急速下跌后,企业差旅与费用管理平台Navan Inc.(NAVN.US)周一获得了华尔街迫切需要的支持,分析师们认为该公司当...
11-25 07:28
Nutanix (NTNX) is scheduled to announce Q1 earnings results on Tuesday, November 25th, after market close. The consensus EPS Estimate is $0.41 (-2.4% Y/Y) and the consensus Revenue Estimate is $676.88...
11-25 06:35
据媒体报道,白宫正准备公布一项政策框架,拟将《平价医疗法案》(又称 “奥巴马医改”)的保费补贴延长两年,并增设新的资格限制。受此消息影响,美国健康保险公司股...
11-24 23:12
WillScot Holdings Corporation, a leading provider of innovative temporary space solutions, announced its participation in two upcoming investor conferences: the Bank of America Leveraged Finance Conference on December 2, 2025, in Boca Raton, Florida, and the Oppenheimer Winter Industrial Summit on December 10-11, 2025, virtually. WillScot offers a wide range of space solutions across North America, with operations spanning the United States, Cana...
11-24 21:30
市场连续第三周陷入动荡,美国股票投资者正急于寻找投资方向 —— 而通常这个时段对股市而言本是季节性强势期。 尽管上周市场剧烈波动的原因尚无简单明确的答案...
11-24 21:11
Chemomab Therapeutics Ltd. announced that its co-founder and CEO, Dr. Adi Mor, will present at Oppenheimer's Movers in Rare Disease Summit on December 11, 2025, in New York City. Dr. Mor will provide a corporate overview and hold one-on-one meetings with attendees. Chemomab is a biotech company developing innovative therapeutics for fibro-inflammatory diseases, particularly focusing on nebokitug, a first-in-class monoclonal antibody targeting CCL...
11-24 13:00
据两名知情人士透露,另类资产管理公司蓝猫头鹰资本(Blue Owl Capital)正考虑重启旗下两只私募信贷基金的合并计划,但前提是规模较大的那只基金股价...
11-24 05:21